Home > Publications database > Toll-like receptor 1 locus re-examined in a genome-wide association study update on anti-Helicobacter pylori IgG titers. > print |
001 | 178524 | ||
005 | 20240229143549.0 | ||
024 | 7 | _ | |a 10.1053/j.gastro.2022.01.011 |2 doi |
024 | 7 | _ | |a pmid:35031300 |2 pmid |
024 | 7 | _ | |a 0016-5085 |2 ISSN |
024 | 7 | _ | |a 1528-0012 |2 ISSN |
024 | 7 | _ | |a altmetric:120969708 |2 altmetric |
037 | _ | _ | |a DKFZ-2022-00121 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Lam, Suk Yee |b 0 |
245 | _ | _ | |a Toll-like receptor 1 locus re-examined in a genome-wide association study update on anti-Helicobacter pylori IgG titers. |
260 | _ | _ | |a Philadelphia, Pa. [u.a.] |c 2022 |b Saunders |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1651150741_30566 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a 2022 May;162(6):1705-1715 |
520 | _ | _ | |a A genome-wide significant association between anti-Helicobacter pylori (H. pylori) IgG titers and Toll-like receptor (TLR1/6/10) locus on 4p14 was demonstrated for individuals of European ancestry, but not uniformly replicated. We re-investigate this association in an updated genome-wide association study (GWAS) meta-analysis for low gastric cancer incidence populations, address potential causes of cohort heterogeneity and explore functional implications of genetic variation at the TLR1/6/10 locus.The dichotomous GWAS (25% individuals exhibiting highest anti-H. pylori IgG titers versus remaining 75%) included a discovery and replication sample of respectively n=15,685 and n=9,676, all of European ancestry. Longitudinal analysis of serological data was performed on H. pylori-eradicated subjects (n=132) and patients under surveillance for premalignant gastric lesions (n=107). TLR1/6/10 surface expression, TLR1 messenger RNA (mRNA) and cytokine levels were measured in leukocyte subsets of healthy subjects (n=26) genotyped for TLR1/6/10 variants.The association of the TLR1/6/10 locus with anti-H. pylori IgG titers (rs12233670; β=-0.267 SE±0.034; P=4.42x10-15) presented with high heterogeneity and failed replication. Anti-H. pylori IgG titers declined within 2-4 years following eradication treatment (P=0.004), and decreased over time in patients with premalignant gastric lesions (P<0.001). Variation at the TLR1/6/10 locus affected TLR1-mediated cytokine production and TLR1-surface expression on monocytes (P=0.016) and neutrophils (P=0.030), but not mRNA levels.The association between anti-H. pylori IgG titers and TLR1/6/10 locus was not replicated across cohorts, possibly due to dependency of anti-H. pylori IgG titers on therapy, clearance and antibody decay. H. pylori-mediated immune cell activation is partly mediated via TLR1 signaling, which in turn is affected by genetic variation. |
536 | _ | _ | |a 313 - Krebsrisikofaktoren und Prävention (POF4-313) |0 G:(DE-HGF)POF4-313 |c POF4-313 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de |
650 | _ | 7 | |a Polymorphism |2 Other |
650 | _ | 7 | |a Single Nucleotide |2 Other |
650 | _ | 7 | |a bacteria |2 Other |
650 | _ | 7 | |a immunity |2 Other |
650 | _ | 7 | |a serology |2 Other |
700 | 1 | _ | |a Mommersteeg, Michiel C |b 1 |
700 | 1 | _ | |a Yu, Bingting |b 2 |
700 | 1 | _ | |a Broer, Linda |b 3 |
700 | 1 | _ | |a Spaander, Manon C W |b 4 |
700 | 1 | _ | |a Frost, Fabian |b 5 |
700 | 1 | _ | |a Weiss, Stefan |b 6 |
700 | 1 | _ | |a Völzke, Henry |b 7 |
700 | 1 | _ | |a Lerch, Markus M |b 8 |
700 | 1 | _ | |a Schöttker, Ben |0 P:(DE-He78)c67a12496b8aac150c0eef888d808d46 |b 9 |u dkfz |
700 | 1 | _ | |a Zhang, Yan |0 P:(DE-He78)d19149dd97b17ce55e70abd2f9e64d3d |b 10 |
700 | 1 | _ | |a Stocker, Hannah |0 P:(DE-He78)104fae0755c89365b7ae32238b3f1f52 |b 11 |u dkfz |
700 | 1 | _ | |a Brenner, Hermann |0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2 |b 12 |u dkfz |
700 | 1 | _ | |a Levy, Daniel |b 13 |
700 | 1 | _ | |a Hwang, Shih-Jen |b 14 |
700 | 1 | _ | |a Wood, Alexis C |b 15 |
700 | 1 | _ | |a Rich, Stephen S |b 16 |
700 | 1 | _ | |a Rotter, Jerome I |b 17 |
700 | 1 | _ | |a Taylor, Kent D |b 18 |
700 | 1 | _ | |a Tracy, Russell P |b 19 |
700 | 1 | _ | |a Kabagambe, Edmond K |b 20 |
700 | 1 | _ | |a Leja, Marcis |b 21 |
700 | 1 | _ | |a Klovins, Janis |b 22 |
700 | 1 | _ | |a Peculis, Raitis |b 23 |
700 | 1 | _ | |a Rudzite, Dace |b 24 |
700 | 1 | _ | |a Nikitina-Zake, Liene |b 25 |
700 | 1 | _ | |a Skenders, Girts |b 26 |
700 | 1 | _ | |a Rovite, Vita |b 27 |
700 | 1 | _ | |a Uitterlinden, André |b 28 |
700 | 1 | _ | |a Kuipers, Ernst J |b 29 |
700 | 1 | _ | |a Fuhler, Gwenny M |b 30 |
700 | 1 | _ | |a Homuth, Georg |b 31 |
700 | 1 | _ | |a Peppelenbosch, Maikel P |b 32 |
773 | _ | _ | |a 10.1053/j.gastro.2022.01.011 |g p. S0016508522000191 |0 PERI:(DE-600)1478699-0 |n 6 |p 1705-1715 |t Gastroenterology |v 162 |y 2022 |x 0016-5085 |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:178524 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)c67a12496b8aac150c0eef888d808d46 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)d19149dd97b17ce55e70abd2f9e64d3d |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-He78)104fae0755c89365b7ae32238b3f1f52 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-313 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Krebsrisikofaktoren und Prävention |x 0 |
914 | 1 | _ | |y 2022 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-02-03 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-02-03 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-02-03 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b GASTROENTEROLOGY : 2021 |d 2022-11-17 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-17 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-17 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-17 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-17 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-17 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2022-11-17 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2022-11-17 |
915 | _ | _ | |a IF >= 30 |0 StatID:(DE-HGF)9930 |2 StatID |b GASTROENTEROLOGY : 2021 |d 2022-11-17 |
920 | 1 | _ | |0 I:(DE-He78)C070-20160331 |k C070 |l C070 Klinische Epidemiologie und Alternf. |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)C070-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|